PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million.Revenues and Gross Profit Margin Increased with More Diverse Customer Base.Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs.Financial Year-End is March 31. …
Read More »PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia–(Newsfile Corp. – February 12, 2025) – PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) (“PharmaCielo” or the “Company”), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today …
Read More »
Matribhumi Samachar English